Skip to main content
Peptron, Inc. logo

Peptron, Inc. — Investor Relations & Filings

Ticker · 087010 ISIN · KR7087010005 KO Manufacturing
Open in API
Filings indexed 226 across all filing types
Latest filing 2023-12-15 Regulatory Filings
Country KR South Korea
Listing KO 087010

About Peptron, Inc.

http://www.peptron.com/

Peptron, Inc. is a biotechnology company specializing in peptide engineering and the development of sustained-release (SR) medications. The company's core focus is its proprietary SmartDepot platform technology, which enables the long-acting formulation of peptide-based drugs to treat chronic and life-threatening disorders. A key area of development is in neurodegenerative diseases, with a notable pipeline candidate being a sustained-release formulation of exenatide, based on patents exclusively licensed from the NIH. Peptron operates its own GMP-compliant manufacturing facility to produce its SR formulations, supporting its progression from pre-clinical research to commercial-stage development.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the upcoming Annual General Meeting (AGM). It specifies the date (2023-12-31) and the purpose (determining shareholders for the 27th AGM). Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or a voting result, it falls under the general regulatory filing category.
2023-12-15 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory announcement from Peptron regarding the setting of a record date for the purpose of potential cash or in-kind dividends. It explicitly states that the actual dividend decision has not yet been made and will be announced separately if approved. Since this is an announcement regarding the administrative process of setting a record date for dividends rather than the declaration of the dividend amount itself, it falls under the category of general regulatory announcements.
2023-12-15 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Peptron' (주식회사 펩트론) covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
투자판단관련주요경영사항(전립선암 및 성조숙증 치료제 '루프원'국내 판권 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Peptron regarding a material business event, specifically a domestic licensing agreement for the drug 'Luprone'. It details the contract parties (LG Chem), duration, and nature of the agreement. Since it is a specific regulatory announcement of a business transaction that does not fit into categories like M&A (which usually implies corporate mergers/acquisitions) or specific financial reports, it falls under the general regulatory filing category.
2023-11-10 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean financial authorities regarding the termination of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This involves the company's own shares and falls under the category of transactions involving the company's own shares (share repurchase/cancellation/termination of trust). Therefore, it is classified as 'Transaction in Own Shares' (POS).
2023-10-04 Korean
신탁계약해지결과보고서
Regulatory Filings Classification · 100% confidence The document is a 'Report on Termination of Trust Agreement' (신탁계약해지결과보고서) filed by Peptron with the Financial Supervisory Service (FSS) in South Korea. It details the termination of a trust agreement related to the company's own shares (treasury shares). Since the document reports on the company's own share transactions (buybacks/trust termination) and does not fit into other specific categories like 'Share Issue' or 'Director's Dealing', it is classified as a transaction in own shares.
2023-10-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.